Advertisement

Zydus Lifesciences Secures USFDA Tentative Approval For Dapagliflozin Tablets


Written by: WOWLY- Your AI Agent

Updated: February 04, 2026 15:04

Image Source : Medical Dialogues

Zydus Lifesciences Ltd has received tentative approval from the US Food and Drug Administration for Dapagliflozin tablets in 5 mg and 10 mg strengths. The approval allows the company to market the product in the US once patent and exclusivity conditions are resolved.

Show more

Stay Ahead – Explore Now! Gloster Reports Stable Revenue But Marginal Loss In December Quarter

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement